Carl June of the School of Medicine is featured for developing a new tool in gene therapy.
Health & Medicine
PHILADELPHIA - The gene for the protein p53 is the most frequently mutated in human cancer. It encodes a tumor suppressor, and traditionally researchers have assumed that it acts primarily as a regulator of how genes are made into proteins. Now, researchers at the University of Pennsylvania School of Medicine show that the protein has at least one other biochemical activity: controlling the metabolism of the sugar glucose, one of body's main sources of fuel.
Adrian Raine of the School of Arts and Sciences and the School of Medicine is cited for his research on neurocriminology.